Suggested Level of Knowlege: Detailed

LOs

BT_PO 1.40 Describe the pharmacology of anti-asthma drugs, including beta 2 agonists, corticosteroids, anticholinergics, leukotriene antagonists and theophylline

BT_PO 1.52 Describe the mechanism of action and effects of sympathomimetic and anticholinergic drugs used clinically

BT_PO 1.53 Describe the pharmacology and clinical application of adrenergic agonists

BT_PO 1.60 Describe the pharmacology of drugs used to manage acute or chronic cardiac failure, including: sympathomimetics, phosphodiesterase inhibitors, digoxin, diuretics, ACE inhibitors, nitrates and beta blockers

BT_PO 1.91 Outline the pharmacology of:

· Thyroid hormone replacement and anti-thyroid drugs

· Glucagon

· Vasopressin and analogues

BT_RT 1.17 With reference to the management of shock, describe the pharmacology of vasopressors and inotropes, including: adrenaline, noradrenaline, phenylephrine, metaraminol, dopamine, dobutamine, phosphodiesterase inhibitors, vasopressin

BT_RT 1.18 With reference to cardiopulmonary resuscitation, describe the pharmacology of adrenaline, vasopressin, amiodarone and lignocaine

SS_OB 1.11 Describe the pharmacology of tocolytic agents with particular reference to beta 2 agonists, calcium antagonists, magnesium, inhalational anaesthetics, nitrates and NSAIDS

Past SAQs

2006.2 Describe the use of different sympathomimetics to treat hypotension occurring as a result of subarachnoid block. Outline the advantages and disadvantages of these agents.

2004.1 Describe the mechanisms of action of inotropes and provide examples.

Sympathomimetics